Search
RCZY690
go.drugbank.com/drugs/DB33931ExperimentalRCZY690 is a small molecule drug. RCZY690 is under investigation in clinical trial NCT07806175 (A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of RCZY690 in Advanced Solid Tumors).
TRTL-729
go.drugbank.com/drugs/DB33923ExperimentalTRTL-729 is a small molecule drug. TRTL-729 is under investigation in clinical trial NCT07811063 (A Study to Test a Single Dose of a New Tablet Formulation of TRTL-729).
Proflavine
go.drugbank.com/drugs/DB01123ApprovedInvestigational3,6-Diaminoacridine. Topical antiseptic used mainly in wound dressings.
Mixtures: Kerr 100 Triple Dye Dispos-AEnoxaparin
go.drugbank.com/drugs/DB01225ApprovedInvestigationalEnoxaparin is a common low-molecular-weight heparin (LMWH) used in the prevention and management of various thromboembolic disorders. … Initially approved by the FDA in 1993, it is administered by a subcutaneous or intravenous injection and marketed by several pharmaceutical companies.
Products: CLEXANE INJECTION 2000 IU (20mg)/0.2 ml, CLEXANE INJECTION 8000 IU (80mg)/0.8 mlBeta-D-Glucose
go.drugbank.com/drugs/DB02379InvestigationalA primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state.
Glutethimide
go.drugbank.com/drugs/DB01437ApprovedIllicitGlutethimide is a hypnotic and sedative. Its use has been largely superseded by other drugs.
D-Tyrosine
go.drugbank.com/drugs/DB03839ExperimentalA non-essential amino acid. In animals it is synthesized from PHENYLALANINE. It is also the precursor of EPINEPHRINE; THYROID HORMONES; and melanin.
Tolmetin
go.drugbank.com/drugs/DB00500ApprovedA non-steroidal anti-inflammatory agent (anti-inflammatory agents, NON-steroidal) similar in mode of action to indomethacin.
Coagulation factor VIIa Recombinant Human
go.drugbank.com/drugs/DB00036ApprovedInvestigationalNovoSeven is a vitamin K-dependent glycoprotein consisting of 406 amino acid residues. Cloned and expressed in hamster kidney cells, the protein is catalytically active in a two-chain form.
3SC009
go.drugbank.com/drugs/DB33951Experimental3SC009 is a biologic drug. 3SC009 is under investigation in clinical trial NCT07815002 (Phase I Clinical Study to Evaluate the Safety and Efficacy of 3SC009 Monotherapy for Patients With Advanced Solid